The Patent Finder

Ilias Biologics Inc.

7 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 11, 2027
    The maintenance fee for COMPOSITIONS CONTAINING EXOSOME CARRYING NF-kB INHIBITORS AND METHODS OF USING THEREOF (US 11,696,939) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
  • 1 fee due Jul 16, 2027
    The maintenance fee for Compositions containing protein loaded exosome and methods for preparing and delivering the same (US 11,872,193) comes due Jul 16, 2027. Unpaid by Jan 18, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,702,581Compositions containing protein loaded exosome and methods for preparing and delivering the same
In force
 · High confidence
In forceHigh confidence
US 11,872,193Compositions containing protein loaded exosome and methods for preparing and delivering the same
In force
 · High confidence
In forceHigh confidence
US 12,133,879Exosomes for Target Specific Delivery and Methods for Preparing and Delivering the Same
In force
 · Medium confidence
In forceMedium confidence
US 12,539,325Exosomes for Target Specific Delivery and Methods for Preparing and Delivering the Same
In force
 · Low confidence
In forceLow confidence
US 11,696,939COMPOSITIONS CONTAINING EXOSOME CARRYING NF-kB INHIBITORS AND METHODS OF USING THEREOF
In force
 · High confidence
In forceHigh confidence
US 12,559,549ANTIBODY BINDING TO SUPER-REPRESSOR IkB (srIkB) OR ANTIGEN BINDING FRAGMENT THEREOF
In force
 · High confidence
In forceHigh confidence
US 12,472,228Use of exosome-based delivery of NF-κB inhibitors
In force
 · USPTO record
In forceUSPTO record

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited